Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To identify differentially expressed genes in hepatocarcinogenesis, we performed differential display analysis using surgically resected
hepatocellular carcinoma
(
HCC
) and adjacent non-tumorous liver tissues. We identified four cDNA fragments upregulated in
HCC
samples, encoding
antisecretory factor-1
(AF), gp96, DAD1 and CDC34. Northern blot analysis demonstrated that these mRNAs were expressed preferentially in HCCs compared with adjacent non-tumorous liver tissues or normal liver tissues from non-
HCC
patients. The expression of these mRNAs was increased along with the histological grading of
HCC
tissues. These mRNA levels were also high in three human
HCC
cell lines (HuH-7, HepG2 and HLF), irrespective of the growth state. We also demonstrate that sodium butyrate, an inducer of differentiation, downregulated the expression of AF and gp96 mRNAs, supporting in part our pathological observation. Immunohistochemical analysis revealed that gp96 and CDC34 proteins were preferentially accumulated in cytoplasm and nuclei of
HCC
cells, respectively. Overexpression of these genes could be an important manifestation of
HCC
phenotypes and should provide clues to understand the molecular basis of hepatocellular carcinogenesis.
...
PMID:Enhanced expression of mRNAs of antisecretory factor-1, gp96, DAD1 and CDC34 in human hepatocellular carcinomas. 1133 99
Angiocidin, a tumor-secreted protein, was measured in serum of 27 healthy volunteers and 33
hepatocellular carcinoma
(
HCC
) patients. Healthy controls either hepatitis B surface antigen (HBsAg) positive or negative showed undetectable levels. Patients had levels of
angiocidin
ranging from 15.09 to 195.73 pg/ml. Patients with stages III-IV had higher levels of
angiocidin
(97+/-13 pg/ml, n=17) compared to those with stages I-II (63+/-37 pg/ml, n=16), p<0.043. Patients with microsatellite tumor nodules had higher average levels (98+/-55 pg/ml, n=17) compared to those without microsatellite nodules (51+/-27 pg/ml, n=20), p<0.032. Our studies suggest that
angiocidin
predicts advanced stage and intra-hepatic metastasis.
...
PMID:Clinical significance of serum angiocidin levels in hepatocellular carcinoma. 1718 26